Skip to main content
    M

    Milestone Scientific (MLSS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.29
    -0.01 (-4.56%)

    Market Cap: $27.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Milestone Scientific (MLSS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Milestone Scientific (MLSS) trades at 3.0x sales and 7.5x book value. Its P/S of 3.0x is below its 5-year median of 6.2x. Its forward P/E is 18.2x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E18.2x
    Price to sales3.0x
    Price to book7.5x
    PEGN/A
    FCF yield-5.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 43.4% below 5.3x and its P/B is 3.8% below 7.8x.

    MultipleCurrent5-year median10-year median
    P/S3.0x6.2x5.3x
    P/B7.5x8.6x7.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 117 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 1.3x in 2018 to 23.1x in 2020.

    Year endPriceP/SP/B
    2025$0.272.5x8.0x
    2024$0.968.8x12.8x
    2023$0.695.1x6.5x
    2022$0.483.8x3.3x
    2021$2.0613.7x8.8x
    2020$2.1223.1x8.6x
    2019$1.397.6x40.8x
    2018$0.331.3x8.7x
    2017$1.183.5x5.7x
    2016$1.403.5x5.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MLSS

    What is MLSS's forward P/E ratio?

    Milestone Scientific has a forward P/E ratio of 18.2x.

    Is MLSS stock overvalued?

    GNG's valuation label for MLSS is Undervalued.

    What is MLSS's price to sales ratio?

    Milestone Scientific has a price to sales ratio of 3.0x.